Startups

Newco news: Hemab targeting rare bleeding disorders with $55M series A

Hemab was formed just over six months ago with seed funding from Novo Seeds. The series A was led by Novo Holdings, Health Cap and RA Capital …

Read more @ www.bioworld.com

Back to top button